2019 bio accounting conference, 2019 bio accounting cpe, 2019 cbi accounting, 2019 cbi accounting coe, 2019 life science accounting, 2019 life science accounting conference, 2019 life science accounting cpe, 2019 life science accounting san jose, 2019 life science accounting seminar, 2019 life science accounting training, 2019 life science leases, 2019 life science revenue recognition, 2019 life science technical accounting, 2019 medical device accounting cpe, 2019 medical device cpe conference, 2019 pharma accounting, 2019 pharma accounting conference, 2019 pharma accounting cpe. 2019 pharma accounting seminar, 2019 pharma accounting san jose, 2019 pharma cpe
Life Science Accounting Update 2019
SAN JOSE
From technical accounting, IPO trends, Gross to Net to cybersecurity and fraud, this conference will address the latest developments in key areas. You’ll hear from experts at the Big Four and regional firms.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $995
This year’s event will be held at The San Jose Hayes Mansion.
You can also register by phone 610 789-3110
or Email questions or to be invoiced to: mtarman@acslive.com
| Agenda: DAY 1 | ||
|---|---|---|
| 8:00 | 8:45 | Continental Breakfast and Registration |
| 8:45 | 10:10 | Collaboration Accounting and Revenue Recognition Update Interaction of 808 and 606 Evaluating “active participation” Measure of progress Options to purchase licenses Options to purchase equity Other SEC comment letter themes ASC 606 Implementation Issues and Examples Working through the five step model Implementation issues and lessons learned in the life science industry |
| 10:10 | 10:25 | Break |
| 10:25 | 12:00 | Gross to Net (GTN) Understanding the Complexities Internal and External Challenges Elements leading to GTN model creation Industry examples |
| 12:00 | 1:00 | Lunch |
| 1:00 | 2:00 | Legal Update: IPO Trends Unicorns and timing give IPOs a lift Geopolitical and trade issues Outlook |
| 2:00 | 2:05 | Break |
| 2:05 | 3:15 | Business Combinations In-License Agreements Asset Acquisitions vs. Business Combination Considerations Industry trends |
| 3:15 | 3:20 | Break |
| 3:20 | 4:20 | Product Launch Considerations Related to US Government Pricing |
| 4:20 | 4:25 | Break |
| 4:25 | 5:30 | Tax Update R&D Tax Credits Tax Accounting Methods Orphan Drug Credit |
| Agenda: DAY 2 | ||
|---|---|---|
| 8:15 | 8:45 | Continental Breakfast |
| 8:45 | 10:15 | SEC & PCAOB Update Comment letter themes MD&A Update Changing regulatory environment Non-GAAP measures ICFR Material weaknesses Cybersecurity disclosures |
| 10:15 | 10:25 | Break |
| 10:25 | 12:00 | Accounting for Leases Overview of New Rules Identifying a Lease Contract Components Lease Classification Recognition and Measurement Ongoing Requirements Practical Expedients Examples |
| 12:00 | 1:00 | Lunch |
| 1:00 | 2:30 | Valuation Update Fair Value Accounting Industry Standars for Valuation Models Valuing IPR&D Projects Valuation and Impairment of Intangible Assets |
| 2:30 | 2:45 | Break |
| 2:45 | 4:15 | Fraud & Cybersecurity in Life Science Recent Trends Cases and examples Cybersecurity |
| Conference Series Speakers Include: |
|---|
| Nathan Mitchell Deloitte & Touche, Partner |
| Dan Coleman Ernst & Young, Partner |
| Kevin Jackson PwC, Director |
| David Nadell Duff & Phelps, Director - Life Science Industry |
| Brianne Loyd Deloitte & Touche, Senior Manager - National Office Consultation |
| Nick Lubold Deloitte & Touche, Manager |
| Vibhor Chandra Deloitte & Touche, Senior Manager |
| Brian Cuneo Latham & Watkins, Partner |
| Shayne Kennedy Latham & Watkins, Partner |
| May Yu Deloitte & Touche, Senior Manager -National Office Consultation |
| Andrew Trivella Deloitte & Touche, Senior Manager |
| PJ Theisen Deloitte & Touche, Senior Manager |
| Jenny Chan Deloitte & Touche, Partner |
| Kevin Dueck Deloitte & Touche, Partner |
| Matt Walton Deloitte & Touche, Partner |
| Kaetlin Liverman Deloitte & Touche, Manager |
| Jonathan Margate Deloitte & Touche, Partner |